Methotrexate use and NAD+/NADH metabolism
in psoriatic keratinocytes

Agata Liszewska; Ewa Robak; Małgorzata Bernacka; Jarosław Bogaczewicz; Anna Woźniacka

doi:10.5114/ada.2020.93379

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2020
vol. 37

Send email

Copy url:

abstract:

Review paper

Methotrexate use and NAD+/NADH metabolism in psoriatic keratinocytes

Agata Liszewska

¹

,

Ewa Robak

¹

,

Małgorzata Bernacka

¹

,

Jarosław Bogaczewicz

¹

,

Anna Woźniacka

¹

Department of Dermatology and Venereology, Medical University of Lodz, Lodz, Poland

Adv Dermatol Allergol 2020; XXXVII (1): 19-22

DOI: https://doi.org/10.5114/ada.2020.93379

Online publish date: 2020/03/09

View full text Get citation

Methotrexate inhibits tetrahydrofolic acid production and influences mitochondrial oxygen uptake and activity of several enzymes in the respiratory chain reactions, which utilize nicotinamide adenine dinucleotide-linked (NAD-linked) substrates. Hyperproliferation of keratinocytes in psoriasis requires oxidative phosphorylation, in which the reduced form of nicotinamide adenine dinucleotide (NADH) is an electron donor. One hypothesis links increased cellular metabolism to the increased NADH/NAD+ ratio; as expected, the topical application of NAD+ (oxidized form of nicotinamide-adenine dinucleotide) resulted in a clinical improvement of psoriatic lesions in one study. Nevertheless, another report revealed reduced fluorescence of NADH in psoriatic plaques. The biological activity of NADH is not limited only to serving as the electron donor. It was also found to regulate gene transcription.

keywords:

Methotrexate use and NAD+/NADH metabolism in psoriatic keratinocytes

Agata Liszewska 1 , Ewa Robak 1 , Małgorzata Bernacka 1 , Jarosław Bogaczewicz 1 , Anna Woźniacka 1

methotrexate, psoriasis, nicotinamide-adenine dinucleotide, spectrophotometry, mitochondria

Agata Liszewska

¹

,

Ewa Robak

¹

,

Małgorzata Bernacka

¹

,

Jarosław Bogaczewicz

¹

,

Anna Woźniacka

¹